Home › Cancer (all types) › NCT07923370
Facial Expression Awareness Training to Understand and Recognize Emotions
Recruiting
The FEATURE Study: Facial Expression Awareness Training to Understand and Recognize Emotions
Who can join
Ages 6 to 13 · All sexes
Full eligibility criteria
Inclusion Criteria: Eligible participants are SPBT who: 1. are between the ages 6-13 2. completed some form of tumor-directed treatment (surgery, chemotherapy, and/or radiation therapy) 3. are off tumor-directed therapy 4. demonstrate difficulties on at least one of the following: 1. Parent- or self-rated Patient-Reported Outcomes Measurement Information System (PROMIS) Peer Relationships Short Form: T-score 1 standard deviation below the mean, which translates to T scores of 40 or below 2. Social Responsiveness Scale-2 (SRS-2): T-score above 60 on any scale 3. Child Behavior Checklist (CBCL): T-score below 30 on social competence scale or T-score above 64 on social problems subscale Exclusion Criteria: Ineligible participants are individuals who: 1. have a genetic condition affecting neurocognitive or social function, or severe developmental delays (excluding NF1, ASD, and Moya Moya) 2. are non-English speaking (FaceSay is only available in English and some assessments only have been validated in English) 4\) a motor or visual limitation that precludes computer use
About the study
The purpose of this research is to find out if a computer-based treatment program, called FaceSay, is a feasible and effective intervention for survivors of pediatric brain tumors (SPBT). The goal of this intervention is to improve survivors' facial affect recognition, social attention, and social adjustment.
What is being tested
- FaceSay (device)
- SuccessMaker Reading (device)
Sponsor: Children's Hospital of Philadelphia · Participants: 40 · Started: Oct 30, 2025
Contact the study team
- Matthew Hocking, PhD (Clinical Psychology) · Phone: 267-426-5561
- Manali Zope, BS (Biological Sciences) · Phone: 267-425-0174
Official record on ClinicalTrials.gov — NCT07923370
Locations in the U.S.
| Pennsylvania | Children's Hospital of Philadelphia, Philadelphia |
Conditions
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.